Dorsey Asset Management LLC lifted its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 32.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 394,791 shares of the conglomerate's stock after buying an additional 97,299 shares during the period. Danaher comprises 9.3% of Dorsey Asset Management LLC's investment portfolio, making the stock its 6th biggest holding. Dorsey Asset Management LLC owned approximately 0.05% of Danaher worth $90,624,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Nordea Investment Management AB grew its holdings in Danaher by 45.5% in the fourth quarter. Nordea Investment Management AB now owns 778,447 shares of the conglomerate's stock valued at $179,043,000 after purchasing an additional 243,300 shares during the last quarter. Bangor Savings Bank raised its position in Danaher by 14.4% during the fourth quarter. Bangor Savings Bank now owns 1,700 shares of the conglomerate's stock worth $390,000 after acquiring an additional 214 shares during the last quarter. Norway Savings Bank lifted its holdings in shares of Danaher by 10.7% in the fourth quarter. Norway Savings Bank now owns 6,185 shares of the conglomerate's stock valued at $1,420,000 after purchasing an additional 596 shares in the last quarter. Fulton Bank N.A. grew its position in shares of Danaher by 2.7% in the fourth quarter. Fulton Bank N.A. now owns 10,516 shares of the conglomerate's stock valued at $2,414,000 after purchasing an additional 280 shares during the last quarter. Finally, Douglas Lane & Associates LLC increased its stake in shares of Danaher by 3.8% during the 4th quarter. Douglas Lane & Associates LLC now owns 330,715 shares of the conglomerate's stock worth $75,916,000 after purchasing an additional 11,989 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.
Insider Buying and Selling at Danaher
In other news, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares in the company, valued at approximately $3,005,442. This represents a 51.01 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 11.10% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
Several equities analysts recently issued reports on DHR shares. Robert W. Baird reduced their price objective on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Barclays lifted their price objective on Danaher from $205.00 to $215.00 and gave the company an "overweight" rating in a research report on Tuesday, April 22nd. Stifel Nicolaus raised Danaher from a "hold" rating to a "buy" rating and set a $260.00 price target on the stock in a research note on Friday, March 14th. Guggenheim reaffirmed a "buy" rating and set a $250.00 price objective on shares of Danaher in a research note on Wednesday, April 23rd. Finally, Wells Fargo & Company dropped their price target on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a research report on Thursday, January 30th. Five analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, Danaher has an average rating of "Moderate Buy" and an average target price of $264.40.
Check Out Our Latest Report on DHR
Danaher Stock Down 2.8 %
Shares of Danaher stock traded down $5.40 on Friday, hitting $189.42. 4,535,806 shares of the company's stock traded hands, compared to its average volume of 3,411,207. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The firm's 50-day moving average is $198.39 and its 200 day moving average is $219.21. The stock has a market cap of $135.56 billion, a P/E ratio of 35.88, a PEG ratio of 2.66 and a beta of 0.80. Danaher Co. has a 52-week low of $171.00 and a 52-week high of $281.70.
Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The company had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. Equities analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.68%. Danaher's payout ratio is 24.85%.
Danaher Company Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles

Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.